1. Discovery of 1, 8-disubstituted-[1, 2, 3]triazolo[4, 5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Issue 18 (15th September 2019) Authors: Qiao, Jingxin; Lin, Guifeng; Xia, Anjie; Xiang, Zhiyu; Chen, Pei; Zhang, Guo; Li, Linli; Yang, Shengyong Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 18(2019) Page Start: 2595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Discovery of 1, 8-disubstituted-[1, 2, 3]triazolo[4, 5-c]quinoline derivatives as a new class of Hippo signaling pathway inhibitors. Issue 18 (15th September 2019) Authors: Qiao, Jingxin; Lin, Guifeng; Xia, Anjie; Xiang, Zhiyu; Chen, Pei; Zhang, Guo; Li, Linli; Yang, Shengyong Journal: Bioorganic & medicinal chemistry letters Issue: Volume 29:Issue 18(2019) Page Start: 2595 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery of 3, 4-dihydrobenzo[f][1, 4]oxazepin-5(2H)-one derivatives as a new class of ROCK inhibitors for the treatment of glaucoma. (1st August 2021) Authors: Sun, Yumeng; Li, Yueshan; Miao, Zhuang; Yang, Ruicheng; Zhang, Yun; Wu, Ming; Lin, Guifeng; Li, Linli Journal: Bioorganic & medicinal chemistry letters Issue: Volume 45(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Discovery of 3, 6-disubstutited-imidazo[1, 2-a]pyridine derivatives as a new class of CLK1 inhibitors. (1st June 2021) Authors: Zhang, Yun; Xia, Anjie; Zhang, Shiyu; Lin, Guifeng; Liu, Jingming; Chen, Pei; Mu, Bo; Jiao, Yan; Xu, Wenwen; Chen, Mingxin; Li, Linli Journal: Bioorganic & medicinal chemistry letters Issue: Volume 41(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Discovery of 6, 7-dihydro-5H-pyrrolo[3, 4-d] pyrimidine derivatives as a new class of ATR inhibitors. (1st May 2022) Authors: Chen, Pei; Bin, Huachao; Jiao, Yan; Lin, Guifeng; Zhang, Yun; Xia, Anjie; Pan, Zhilin; Qiao, Jingxin; Guo, Yinping; Liu, Jingming; Zhou, Yangli; Li, Linli Journal: Bioorganic & medicinal chemistry letters Issue: Volume 63(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Discovery of human TyrRS inhibitors by structure-based virtual screening, structural optimization, and bioassays. Issue 16 (22nd March 2019) Authors: Huang, Shenzhen; Wang, Xiang; Lin, Guifeng; Cheng, Jie; Chen, Xiuli; Sun, Weining; Xiang, Rong; Yu, Yamei; Li, Linli; Yang, Shengyong Journal: RSC advances Issue: Volume 9:Issue 16(2019) Page Start: 9323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. (8th March 2021) Authors: Guo, Yinping; Mao, Xin; Xiong, Liang; Xia, Anjie; You, Jing; Lin, Guifeng; Wu, Chengyong; Huang, Luyi; Wang, Yiwei; Yang, Shengyong Journal: Angewandte Chemie Issue: Volume 133:Number 16(2021) Page Start: 8842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Structure‐Guided Discovery of a Potent and Selective Cell‐Active Inhibitor of SETDB1 Tudor Domain. Issue 16 (8th March 2021) Authors: Guo, Yinping; Mao, Xin; Xiong, Liang; Xia, Anjie; You, Jing; Lin, Guifeng; Wu, Chengyong; Huang, Luyi; Wang, Yiwei; Yang, Shengyong Journal: Angewandte Chemie international edition Issue: Volume 60:Issue 16(2021) Page Start: 8760 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗